Ribosome Research Centre Pvt. Ltd.Ribosome Research Centre Pvt. Ltd.Ribosome Research Centre Pvt. Ltd.Ribosome Research Centre Pvt. Ltd.

Pharmacovigilance & Drug Safety

The Public Website Does Not Currently Present A Dedicated Pharmacovigilance Service Page. The Following Is Recommended Expansion Content And Should Be Published Only After Confirming Operational Capability And Applicable Regional Requirements.

Our clinical services

Pharmacovigilance & Drug Safety

Our pharmacovigilance model is designed to support the identification, assessment, documentation and communication of emerging safety information throughout clinical development and post-marketing use.

Pharmacovigilance & Drug Safety Scope

  • Individual Case Safety Report (ICSR) Intake, Triage And Processing
  • Case Validation And Duplicate Assessment
  • Medical Review And Clinical Assessment
  • Seriousness, Expectedness And Causality Assessment Support
  • MedDRA / Controlled Terminology Coding
  • Safety Narrative Preparation
  • Regulatory Safety Reporting Support
  • Follow-Up Case Management
  • Signal Detection And Signal Evaluation Support
  • Aggregate Safety Reporting
  • Pharmacovigilance System Documentation
  • Safety Database Support
  • Medical Information / Product-Information Support

Pharmacovigilance Workflow

  1. Case Intake
  2. Validation & Triage
  3. Medical Review
  4. Coding Narratives
  5. Submission / Follow-Up
  6. Signal & Aggregate Review

Potential Deliverables

  • ICSR Packages
  • Safety Narratives
  • Literature Screening Records
  • Signal Evaluation Reports
  • PSUR/PBRER Support
  • DSUR Support
  • RMP Support
  • PSMF Support
  • Safety Database Reconciliation

Stay connected with science

Stay Informed. Stay Ahead in Research.

Subscribe to receive the latest updates on pharmaceutical research, clinical and pre-clinical testing, medical device safety, regulatory developments, scientific insights and industry events from Ribosome Research Centre.